Company Overview
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.21.
Recent Developments
- Sep 2025 Revenue of $18.67M (-21.7% YoY); net profit $-1.99M.
- Trailing 12 Months Year-on-year growth — revenue -21.7%, earnings -601.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -14.5%, profit CAGR -44.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -14.54% |
| 1 Year: | -21.70% |
Compounded Profit Growth
| 5 Years: | -43.99% |
| 1 Year: | -600.98% |
Stock Price Performance
| 1 Year: | -14.50% |
| 6 Months: | -24.83% |
| 3 Months: | -15.15% |
| 1 Month: | +4.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.59 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -14.5% CAGR over 5 years.
- Earnings shrank at -44.0% CAGR over 5 years.
- Trading 50.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BON Bon Natural Life Limited | 1.12 | -1.56 | $6.82M | 0.00% | -2.28% | -4.00% | -14.54% | -43.99% |
| 2 | LIN Linde plc NDXSPXR3K | 468.38 | 30.22 | $215.91B | 1.40% | 12.46% | 18.40% | 13.90% | 18.47% |
| 3 | SCCO Southern Copper Corporation R3K | 208.56 | 31.27 | $176.10B | 2.24% | 36.40% | 49.90% | 8.32% | 3.80% |
| 4 | NEM Newmont Corporation SPXR3K | 127.09 | 16.01 | $133.91B | 0.84% | - | 25.91% | 6.53% | 20.15% |
| 5 | RIO Rio Tinto Group | 103.83 | 14.07 | $130.27B | 4.78% | 13.65% | 19.31% | 1.24% | -7.00% |
| 6 | FCX Freeport-McMoRan Inc. SPXR3K | 76.62 | 37.56 | $110.03B | 0.78% | 12.50% | 14.75% | 1.35% | -1.26% |
| 7 | AEM Agnico Eagle Mines Limited | 201.84 | 17.27 | $102.20B | 0.88% | 19.78% | 22.97% | 27.53% | 88.11% |
| 8 | SHW The Sherwin-Williams Company SPXR3K | 326.09 | 30.05 | $79.16B | 1.00% | 21.93% | 65.12% | 6.18% | 8.26% |
| 9 | ECL Ecolab Inc. SPXR3K | 278.11 | 37.33 | $77.96B | 1.05% | 15.10% | 21.96% | 6.55% | 9.74% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 29.91M | 29.52M | 23.84M | 18.67M |
| Cost of Revenue | - | 20.48M | 20.68M | 16.73M | 14.79M |
| Gross Profit | - | 9.42M | 8.84M | 7.11M | 3.88M |
| Operating Expenses | - | 1.52M | 2.88M | 5.17M | 5.46M |
| Operating Income | - | 7.91M | 5.96M | 1.94M | -1.59M |
| EBITDA | - | 8.38M | 6.99M | 2.30M | -57.82K |
| Interest Expense | - | 446.82K | 238.17K | 303.25K | 366.18K |
| Pretax Income | - | 7.57M | 5.57M | 715.94K | -1.71M |
| Tax Provision | - | 1.27M | 1.00M | 351.18K | 339.41K |
| Net Income | - | 6.24M | 4.60M | 398.17K | -1.99M |
| Diluted EPS | 170.00 | 185.75 | 124.92 | 4.14 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 37.26M | 46.56M | 61.77M | 85.19M |
| Current Assets | - | 14.72M | 24.18M | 39.79M | 45.76M |
| Cash & Equivalents | - | 840.86K | 111.30K | 80.47K | 3.77M |
| Inventory | - | 1.72M | 987.29K | 1.57M | 3.31M |
| Receivables | - | 6.78M | 4.60M | 11.78M | 11.01M |
| Total Liabilities | - | 7.16M | 10.57M | 17.42M | 27.19M |
| Current Liabilities | - | 6.65M | 9.61M | 16.45M | 26.31M |
| Long Term Debt | - | 189.81K | 871.37K | 970.06K | 842.82K |
| Total Debt | - | 5.41M | 4.12M | 7.30M | 12.29M |
| Total Equity | - | 29.56M | 35.48M | 43.91M | 57.55M |
| Shares Outstanding | - | 33.58K | 46.95K | 158.82K | 8.13M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -187.12K | -616.90K | -7.72M | 141.12K |
| Investing Cash Flow | - | -3.06M | -1.19M | -15.73K | -10.00M |
| Financing Cash Flow | - | 2.26M | 1.16M | 8.76M | 15.45M |
| Capital Expenditure | - | -2.07M | -731.10K | -7.05K | -10.00M |
| Free Cash Flow | - | -2.26M | -1.35M | -7.73M | -9.85M |
| Net Change in Cash | - | -981.26K | -647.32K | 1.02M | 5.60M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 31.5% | 29.9% | 29.8% | 20.8% |
| Operating Margin % | - | 26.4% | 20.2% | 8.1% | -8.5% |
| Net Margin % | - | 20.9% | 15.6% | 1.7% | -10.7% |
| ROE % | - | 21.1% | 13.0% | 0.9% | -3.5% |
| ROCE % | - | 25.8% | 16.1% | 4.3% | -2.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Xtx Topco Ltd | 0.26% | 15.66K | $18.67K |
| 2 | Citadel Advisors Llc | 0.21% | 12.62K | $15.04K |
| 3 | Two Sigma Securities, LLC | 0.18% | 10.84K | $12.92K |
| 4 | UBS Group AG | 0.01% | 415 | $494 |
| 5 | Caitong International Asset Management Co., Ltd | - | 7 | $8 |
| 6 | Osaic Holdings Inc. | - | 1 | $1 |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BON
Bon Natural Life Ltd - 24/7 Wall St.
<a href="https://news.google.com/rss/articles/CBMiTEFVX3lxTFBtSTJPRUkxdTNGcWUzV1p0eXhvYkhjNWY3SERxVDc5T3NDYUxST0V3cXQ5R3pXTHNEOTBrZE80RmRFXzJiV3dWbF9iMXE?oc=5" target="_blank">Bon Natural Life Ltd</a> <font color="#6f6f6f">24/7 W…
Bon (BON) Market: Records a 0.87% Decrease to $1.14 in Latest Trading; Levels: the Supplied Trading Band Runs From $1.08 to $1.20 - Advance Decline Line - vinanet.vn
<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxQVzZqLS1NRUpDb0l6d05OUHZwX2swMkRiMW96N2h6dV9udlNJWTJjX1FmM2JYVi12djBJc3N1VjBDUEdCdHFhWXJNSW03Znkwd1JkSEU0dXBoaEU4aU5JYjQzeUFhdDRQck9KaVQ2bU90VDR6NTY3VzdOZ3h6SWdZRmJ4bVVWOC10dmJpVT…
Bon Natural Life Ltd (BON) Key Financial Ratios – Valuation, Profitability & More - Value Research
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPNmZHV1lfbTZIQU5uazVicnQzcmZwODB0T0p2MjJSOS16Ti1aclA1TFVsR01yVmRfNzJKNEY2bWtubXktOXFIdkFBTnlMT3FVYVp0QkxfZENydFZtSnQ4R3dta0VKNFVMQm9ybFhvZUc2LVl1N2xvUWZQaENKZnVHc0t2cFc0NXVPYWs4T3…
Ready for a Wellness Reset? Stock Your Pantry With These Snacks, Drinks, and Supplements - Bon Appétit: Recipes, Cooking, Entertaining, Restaurants | Bon Appétit
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1FSUtRMGxEZk9paWlaMnJmcjdBazZ2NWhqM011cHAxb1A5d3JHSUxfM3NOclVOWWxERVN3UGlpeXM0Ym9MT3dGT29pX2ZqV3N4Qk45eUtKZUNialhKUGlmeGNYYWpCZGJuVzZjWA?oc=5" target="_blank">Ready for a Wellness …
Korean Firms Restructure Shares for Succession Amid Stock Declines - 조선일보
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNWVg2Uzdpa3M0ZFVEbE1rUjJJSzlic2VLcS1uWGVzOXlaYXJtUXFYQ29NMW5yRERTSFQ4dGFGYURHb3laalVIa1A1UEx1bkM2NnQ1XzhrUjAxd3UzVDJkRkkzMFM3Rk5nRjlTalZvOERfeFdWQkl3eGpCcTNtNzEzWm1mX1lyWHh5?oc=5"…
Millie Bobby Brown Shares How Jon Bon Jovi Spends Grandpa Duty with Her and Jake Bongiovi's Daughter - People.com
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOV0RkYjh4UGI2Vy1SMGRTNlRadVBRZDBYNkR5QnJia3NjNXhsb1l1bzZ6NzZKR3NaRzgyZnNVcHRFYmdHZWlFTVNaMkxzNlo4VFZSbWdHX2dFSkkyaXcxeHpVeTJHdTZNVmVZNktLeE5IbWtIQmgyTzNSQzhUUDRaUjZXdkVTWElfZDdlTj…
BON — Frequently Asked Questions
What is the current share price of Bon Natural Life Limited (BON)?
As of 2026-09-19 21:16 PDT, Bon Natural Life Limited (BON) trades at $1.12 on NasdaqCM. Its 52-week range is $1.05 to $2.28.
What is the market capitalisation of BON?
Bon Natural Life Limited (BON) has a market capitalisation of $6.82M on NasdaqCM.
What is the P/E ratio of BON?
BON trades at a trailing price-to-earnings (P/E) ratio of -1.56. The industry average P/E is 22.16. Its price-to-book (P/B) ratio is 0.13.
What is the return on equity (ROE) of BON?
BON has a return on equity (ROE) of -4.00%. Its return on capital employed (ROCE) is -2.28%.
Is BON a good stock to buy?
This page provides a data-driven analysis of Bon Natural Life Limited (BON), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.